Nausea and vomiting

Published on 13/02/2015 by admin

Filed under Gastroenterology and Hepatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1654 times

9 Nausea and vomiting

Case

A 21-year-old university student consults because of episodic nausea and vomiting. In between attacks, he is well. However, approximately every 2 months he will experience worsening nausea preceding violent vomiting episodes that can last for 3–5 days. The vomiting has been so severe that he has presented to casualty where intravenous injections of antiemetics have been given. There is mild abdominal pain associated with the nausea and vomiting at times. His bowel habit has been normal. He denies any neurological symptoms. He has had a history of occasional migraine-type headaches, but has otherwise been in excellent health. He has not been taking any regular medications. He has already seen a gastroenterologist who performed an upper endoscopy that was normal and a small bowel x-ray that was normal. Screening blood tests (including electrolytes, liver function tests and a blood count) have all been normal.

You ask him two specific questions. First, you ask whether he feels the compulsion to take a hot bath or shower during an episode; while the patient is surprised by the question he acknowledges this is true and this seems to help. You also ask him whether he has ever used marijuana. The patient admits he has from time to time smoked marijuana to try to prevent his symptoms.

Physical examination is completely unremarkably, including a full neurological examination and fundoscopy.

You make an astute diagnosis of cyclic vomiting syndrome secondary to cannabis use. You explain to the patient that in some cases vomiting can be precipitated by use of marijuana. You strongly encourage him to cease all marijuana use. A prescription for a tricyclic antidepressant (desipramine) is subsequently given because the attacks do continue off cannabis. The dose is slowly titrated up, and the patient has an excellent response with a substantial reduction in the number of vomiting episodes over the subsequent 6 months.

Physiology of Vomiting

With the onset of nausea, there will be accompanying autonomic discharge of variable severity. This results in intense salivation, bradycardia, sweating, pallor and hypotension. The normal electrical activity of the stomach may become slow, fast or fluctuate wildly with nausea. It is unclear whether the same neural pathways that mediate vomiting also mediate nausea.

Just prior to vomiting, a large amplitude contraction in the small bowel is propagated retrogradely. Moderate amplitude phasic contractions may also occur in the small intestine, with these motor activities probably being mediated by the vagus nerve. These motor changes result in the small bowel contents entering the relaxed stomach where closure of the pylorus then occurs with contraction of the abdominal muscles, causing respiration to be suspended. Gastric contents are then forced against a contracted diaphragm, the lower oesophageal sphincter relaxes and the cardia elevates. Gastric contents are forced into the oesophagus, which dilates. Protection of the airway occurs via the glottis closing and the soft palate rising, and then the vomitus is forcibly ejected from the mouth.

The vomiting centre is located in the dorsal portion of the medulla. The vomiting centre has afferent inputs via vagal fibres, which are rich in 5-hydroxytryptamine type 3 (5-HT3) receptors. There is afferent input from sympathetic nerves. There is also input from the vestibular system, which is rich in histamine H1 and muscarinic cholinergic fibres. The chemoreceptor trigger zone is in the area postrema in the floor of the fourth ventricle. This area, when stimulated, will activate the vomiting centre, and is responsive to drugs, hypoxia, toxins and acidosis; it is rich in dopamine D2 and 5-HT3 receptors. The presence of these receptor subtypes forms the rationale for drugs used to treat nausea and vomiting. Other trigger areas include the pharynx, coronary vessels, peritoneum and bile ducts, cortex, thalamus and hypothalamus, and the vestibular apparatus (motion sickness).

History

Nausea and vomiting are non-specific symptoms and may occur in many diseases. Box 9.1 lists the important causes of nausea and vomiting. When taking the targeted history, it is key to differentiate between vomiting, regurgitation and rumination.

It is very helpful to determine the duration, frequency and intensity of nausea and vomiting, and its relationship to eating. Self-limiting symptoms will often occur with an acute infectious gastroenteritis, with inflammatory disease such as cholecystitis or pancreatitis, or from drugs. Gastroenteritis is usually associated with headache, myalgias and diarrhoea and will settle within 5 days, so a longer duration of symptoms should raise the suspicion of another cause. An insidious onset of nausea without vomiting can occur with functional dyspepsia, gastroparesis, medication use, gastro-oesophageal reflux disease, pregnancy and metabolic disorders. Vomiting on waking in the morning may occur from excess alcohol use the night before. Early morning vomiting can also occur with pregnancy, renal failure and raised intracranial pressure.

The character of the vomit is useful to document. Undigested food in the vomit may occur from oesophageal disorders (e.g. achalasia or Zenker’s diverticulum). Gastric outlet obstruction may result in partially digested food, free of bile. In small bowel obstruction, the vomitus is usually bile stained. Faecal vomiting indicates distal small bowel obstruction or a gastrocolonic fistula.

The presence of other gastrointestinal symptoms such as abdominal pain or diarrhoea suggests a primary gastrointestinal disease. In the presence of significant weight loss with nausea and vomiting, consideration needs to be given to a gastrointestinal tract malignancy, intestinal obstruction or an eating disorder. An adolescent female with a history of repeated bouts of vomiting immediately after meals, particularly after binge eating, may have anorexia nervosa or bulimia nervosa; accompanying weight loss, fear of gaining weight, impaired body image, amenorrhoea and binge eating should be asked about. The vomiting is generally self-induced; laxatives, diuretics and vigorous exercise may also be used to prevent weight gain (Ch 17).

Diseases of the central nervous system can present with vomiting. This may manifest as sudden projectile vomiting without nausea. Emesis may also be triggered by an abrupt change in body position. It is unusual for a patient with a brain tumour to present with vomiting in the absence of other neurological symptoms such as headache, vertigo, deafness, tinnitus or visual impairment.

If the patient describes acute episodes of nausea and vomiting separated by intervening totally asymptomatic periods, this is suggestive of cyclical vomiting, which can occur in adults but is much more common in children; a history of migraine may be present.

Symptoms of systemic diseases that may cause nausea and vomiting, including diabetes mellitus, renal failure, hypercalcaemia and hyperthyroidism, should be actively sought.

Gastro-oesophageal reflux disease can present with recurrent vomiting in the absence of heartburn and acid regurgitation.

Chronic nausea with little or no vomiting, and not accompanied by other symptoms or signs, presents a diagnostic challenge. Organic diseases rarely cause chronic persistent nausea alone.

In the first trimester of pregnancy, nausea and vomiting are common. All women of childbearing age should have pregnancy excluded as a cause.

Investigation

Investigation is undertaken to:

The investigations need to be guided by the initial history and physical examination. Serum electrolytes will exclude hypokalaemia, renal failure and metabolic alkalosis due to chronic loss of gastric contents. Serum albumin levels, if low, would suggest a chronic disease or malnutrition. Anaemia would suggest colonic or small bowel disease, whereas leucocytosis would suggest an inflammatory process. If there is upper abdominal pain, pancreatic and liver enzymes can be useful. Peripherally, eosinophilia can occur in eosinophilic gastroenteritis, which can present with recurrent vomiting. Pregnancy testing is mandatory before radiographic testing in any woman of reproductive age with new-onset nausea and vomiting.

A suggested management algorithm for chronic nausea and vomiting is shown in Figure 9.1. Supine and upright abdominal x-rays will document small bowel obstruction, although in 20% of cases partial small bowel obstruction can be missed with plain films. Upper endoscopy will exclude gastric outlet obstruction and significant gastroduodenal disease, such as peptic ulcer. If small-bowel follow-through fails to reveal evidence of obstruction, which can occur with a partial lesion, an enteroclysis (where barium and methylcellulose are infused into the proximal intestine via a nasojejunal tube in order to provide double-contrast pictures) or computed tomography enterography can be useful. If there is any suggestion of lower bowel obstruction, barium enema or colonoscopy should be undertaken.

Endocrine disease may present with chronic vomiting and, therefore, testing should be done to exclude diabetes mellitus, hypothyroidism and, in particular, Addison’s disease.

If the patient has normal structural evaluations and continues to be symptomatic, gastric emptying testing can be undertaken. An alternative is 13C octanoic acid breath testing, which is non-radioactive and can be used in children or pregnant women. However, symptom improvement on prokinetics correlates poorly with changes in gastric emptying, and abnormal emptying is not a reliable way to direct management of nausea and vomiting. Another controversial test is electrogastrography. Cutaneous electrodes can measure the gastric slow wave activity. In the setting of vomiting, there may be slow (bradygastria) or fast (tachygastria) myoelectric rhythms, but this has not been established to be useful for directing treatment of chronic nausea or vomiting. Antroduodenal manometry is valuable in specialised centres. Approximately 40% of patients with unexplained nausea and vomiting have normal results, and the test alters management in only about 10% of cases. It is useful to consider this test when symptoms continue to be very troublesome; normal results of antroduodenal manometry should direct evaluation outside the gastrointestinal tract, which is of value.

Consequences of Nausea and Vomiting

The main complications with acute vomiting include trauma to the distal oesophagus as well as severe fluid and electrolyte disturbances.

Recurrent vomiting may result in laceration of the oesophageal mucosa at the gastro-oesophageal junction, and a small amount of blood may streak the vomitus, typically following repeated vomiting. Haemorrhaging may occur as a consequence of a laceration to the mucosa into the submucosa, termed a Mallory-Weiss tear. If the laceration extends through the submucosa and the serosa to result in an oesophageal perforation, this is called Boerhaave’s syndrome. This perforation typically enters the left chest cavity, producing intense pain. Acute severe vomiting, particularly in patients with neurological defects or impaired consciousness from alcohol intoxication, may result in aspiration of vomitus into the lungs.

Recurrent vomiting in young and elderly people, particularly, may result in severe fluid and electrolyte disturbances. Most of these losses occur from the vomited secretions of the stomach and upper small intestine. As hydrogen, sodium, potassium and chloride irons are lost from gastric secretions, prolonged vomiting results in metabolic alkalosis, hypokalaemia and dehydration.

Occasionally, a patient who is vomiting will conceal it and present with unexplained hypochloraemic hypokalaemic metabolic alkalosis. Here, the differential diagnosis includes surreptitious diuretic use, primary hyperaldosteronism and Bartter’s syndrome. The urine chloride is typically low with vomiting (or diuretics).

Chronic nausea and vomiting significantly impair quality of life, and warrants appropriate therapy.

Important Diseases that may cause Nausea and Vomiting

Gastric and intestinal obstruction

The nature of vomiting and associated symptoms caused by intestinal obstruction depends on the level of the gut involved as well as the rapidity with which the obstruction occurs (Ch 4). Acute small bowel obstruction is more likely to be associated with severe pain compared with obstruction of a more insidious onset. Bile is almost always present in the vomitus when the obstruction is below the duodenal ampulla. The vomiting of partially digested food one to several hours after eating would suggest obstruction at the pylorus. Malignant obstruction of any form is usually accompanied by anorexia and weight loss. Complete obstruction of the stomach or duodenum usually results in the loss of large volumes of fluid in the vomitus (Ch 4).

Functional obstruction, as seen in diabetic gastroparesis or postvagotomy, differs from mechanical gastric obstruction in that intense nausea and anorexia are more common; signs of peripheral and autonomic neuropathy are usually present if diabetes mellitus is the cause. Postprandial fullness and early satiety are common symptoms with diabetic gastroparesis.

Physical examination of the abdomen varies depending upon the cause of the obstruction. In pyloric obstruction, upper abdominal distension and a succussion splash may be observed. Generalised abdominal discomfort may be noted. Distended loops of bowel are observed with peristaltic rushes early in intestinal obstruction, but absent bowel sounds are noted later.

Infection

Acute viral gastroenteritis may result in vomiting. Bacterial gastroenteritis induces vomiting usually accompanied by fever and diarrhoea (see Ch 13). Nausea and vomiting, which occasionally may be prolonged and result in dehydration, may be prominent characteristics of acute viral hepatitis (Ch 24).

Psychiatric disease

Nausea and vomiting are prominent symptoms in eating disorders, including anorexia nervosa and bulimia nervosa (Ch 17). Panic attacks can also cause nausea. If nausea is not accompanied by anorexia or is associated with weight gain, an organic cause is rarely observed.

Principles of Treatment

Treatment involves successfully correcting any dehydration and electrolyte abnormalities. Malnutrition should also be corrected, if present. If clinically necessary, intravenous fluids (normal saline with potassium) should be given and a nasogastric tube put in place; the output, which should be replaced intravenously, should be measured.

Dietary modification is particularly important if there is evidence of gastroparesis. Frequent small meals (six per day), a low-fat diet, avoidance of indigestible material to reduce the chance of bezoar formation and reduced fibre intake can all be useful. Splitting the ingestion of liquids and solids may reduce symptoms. Liquids are generally tolerated better than solids in this setting, and so the use of a blender or liquid formulas can be helpful. Medical therapy (Table 9.1) may be necessary.

Medical therapy

Antiemetics

Neuroleptic agents such as prochlorperazine, chlorpromazine or haloperidol have both anticholinergic and antihistamine effects as well as blocking dopamine D2 receptors in the chemoreceptor trigger zone. Sedation, blood dyscrasias, dystonia and jaundice are potential side effects. Prochlorperazine (5–10 mg three times a day) is most widely used and can be given orally, rectally or parenterally.

Motion sickness is treated with anticholinergic agents such as scopolamine. This can be given as a transdermal patch. Sometimes this will also help gastrointestinal causes of nausea and vomiting. H1-receptor antagonists such as promethazine (25 mg four times a day) or diphenhydramine (25–50 mg three to four times a day) can be helpful in vestibular disturbances and motion sickness, and sometimes improve gastrointestinal-related nausea.

5-HT3 antagonists (e.g. ondansetron, granisetron and dolasetron) are useful in postoperative vomiting, in prevention of chemotherapy-induced emesis and after radiation therapy, but appear to produce relatively little improvement in other forms of vomiting. Tetrahydrocannabinol and nabilone have proven useful in chemotherapy-induced emesis. These cannabinoids can produce drowsiness, orthostatic hypotension, dry mouth and tachycardia, as well as anxiety, depression and visual hallucinations.

The neurokinin-1 antagonist aprepitant is indicated for chemotherapy-induced nausea and vomiting. It is given orally (80–125 mg) and side effects include somnolence, fatigue and hiccups. Talnetant and osanetant are other neurokinin antagonists. Any benefit in gastrointestinal disease is uncertain.

Specific Clinical Scenarios

Functional vomiting

This is a rare condition that has been defined by the Rome Foundation Committee (Box 9.2). If gastric emptying is delayed, it is important to exclude chronic intestinal pseudo-obstruction as well as mechanical intestinal obstruction. No medications have established efficacy in this group, but anecdotally, tricyclic antidepressants seem to be of value and can be tried at a low dose, but may require full dose to be efficacious.